ABL1

Across TCGA pan-cancer cohorts, ABL1 mass-spec protein differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of ABL1’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where ABL1 mass-spec protein is repressed in tumor relative to normal tissue. In most cancer types ABL1 is over-expressed in tumor, although a few such as COAD and LSCC show the opposite, repressed pattern.

COAD, LSCC, and LUAD are the cancer types where ABL1 tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in ABL1 mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	All	III,IV	−0.500	<.001	9	view →
LSCC	Female	II,III,IV	−0.246	<.001	8	view →
LUAD	All	All	+0.044	.032	2	view →
CCRCC	All	III,IV	−0.084	.048	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

ABL1–COAD

Open the COAD breakdown →